News | May 25, 2021
Astrazeneca Pharma India Q4FY21 net profit up at Rs 27.27 Cr
The company has reported total income of Rs.826.40 crores for FY 2020-21
The company has reported total income of Rs.826.40 crores for FY 2020-21
This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips
The company is working closely with its six manufacturing partners in India
The agreement will help ensure wider reach and access to patients in India
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
Essential medicines were made available to more than 150 countries around the world during the pandemic
Subscribe To Our Newsletter & Stay Updated
